TriGalNAc CBz
99%
- Product Code: 76600
Alias:
5-[(3,4,6-Tri-O-benzoyl-2-acetylamino-2-deoxy-Β-D-galactopyranosyl)oxy]-pentanoic acid
CAS:
186613-57-0
| Molecular Weight: | 633.64 g./mol | Molecular Formula: | C₃₄H₃₅NO₁₁ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
TriGalNAc CBz is widely used in glycobiology research for studying carbohydrate-protein interactions, particularly in the context of lectin binding and cell surface recognition. It serves as a key intermediate in the synthesis of complex glycoconjugates, enabling the development of glycan-based probes and inhibitors. This compound is also utilized in the preparation of glycosylated peptides and proteins, which are essential for understanding biological processes like immune response and pathogen recognition. Additionally, it plays a role in the design of glycotherapeutic agents and vaccines, contributing to advancements in targeted drug delivery and immunotherapy.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Off-white Solid |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $882.92 |
+
-
|
| 0.025 | 10-20 days | $2,169.74 |
+
-
|
| 0.100 | 10-20 days | $4,687.01 |
+
-
|
TriGalNAc CBz
TriGalNAc CBz is widely used in glycobiology research for studying carbohydrate-protein interactions, particularly in the context of lectin binding and cell surface recognition. It serves as a key intermediate in the synthesis of complex glycoconjugates, enabling the development of glycan-based probes and inhibitors. This compound is also utilized in the preparation of glycosylated peptides and proteins, which are essential for understanding biological processes like immune response and pathogen recognition. Additionally, it plays a role in the design of glycotherapeutic agents and vaccines, contributing to advancements in targeted drug delivery and immunotherapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :